Spyglass DS Peroral Cholangioscope Guided LL or EHL Versus BML for Endoscopic Removal of Complicated Bile Duct Stones
- Conditions
- Biliary Stones
- Interventions
- Device: Spyglass DS cholangioscopeDevice: BML
- Registration Number
- NCT03244163
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
This study aims to compare the overall rate of endoscopic clearance of complicated bile duct stones by Spyglass DS peroral cholangioscopy guided holmium:YAG laser/electrohydraulic lithotripsy versus conventional BML.
- Detailed Description
Currently, complicated bile duct stones are removed during endoscopic retrograde cholangiopancreatography (ERCP) by conventional mechanical lithotripsy, which means using a metal wire basket to capture the stone and crush it to make it easier to remove. This is successful in approximately 70% of patients, with the success rate inversely correlated to the size of the stone. Unsuccessful stone removal would require additional endoscopic, percutaneous or surgical interventions. Spyglass DS peroral cholangioscope-guided holmium:YAG laser/electrohydraulic lithotripsy is a recent alternate method for managing complicated bile duct stones. Also performed during ERCP, a thin flexible camera (called Spyglass DS peroral cholangioscope) is inserted into the bile duct to visualize the stone which can then be targeted by a laser beam for fragmentation (also known as laser lithotripsy). The smaller pieces are then removed. Direct comparisons of these procedures' efficacy however have not been performed.
The purpose of this study is to compare the efficacy and safety of Spyglass DS peroral cholangioscope-guided holmium:YAG laser/electrohydraulic lithotripsy (the laser arm) versus conventional basket mechanical lithotripsy alone (the conventional arm) for fragmentation and clearance of complicated bile duct stones.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 86
- Patients with complicated biliary stones
- Patients older than 18 years old
- Patients where informed consent can be obtained
- Patients who cannot give informed consent
- Patients under 18 years old
- Pregnant or lactating patients
- Patient with altered gastrointestinal/biliary anatomy
- Patients with distal CBD malignant stricture from intrinsic or extrinsic causes
- Patients with ongoing cholangitis or biliary pancreatitis
- Patient with refractory bleeding tendencies (Platelet count <50,000/mm3 or International Normalized Ratio >1.5 despite correction with platelet or fresh frozen plasma transfusions)
- Patients with intrahepatic segmental stones
- Patients with contraindications to endoscopy due to comorbidities
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description LASER ARM Spyglass DS cholangioscope Spyglass DS cholangioscope guided laser or electrohydraulic lithotripsy CONVENTIONAL ARM BML Stone removal by conventional techniques, for example BML, without laser lithotripsy
- Primary Outcome Measures
Name Time Method Overall rate of endoscopic bile duct stone clearance Intraoperative Overall rate of endoscopic bile duct stone clearance
- Secondary Outcome Measures
Name Time Method Incidence of adverse events 30 days Incidence of adverse events
Technical feasibility Intraoperative Technical feasibility defined as successful introduction of cholangioscope into the CBD, visualisation and laser targeting of stone
Need for and number of additional procedures for stone clearance 6 months Need for and number of additional procedures for stone clearance
Trial Locations
- Locations (1)
Endoscopy Centre, Prince of Wales Hospital
ðŸ‡ðŸ‡°Hong Kong, NT, Hong Kong